The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics (Wellcome Open Research, 2023)

(untitled) - Bourner, J; Salam, AP; Jaspard, M; Olayinka, A; Fritzell, C; Goncalves, B; Vaillant, M; Edwards, T; Erameh, C; Ajayi, N; Ramharter, M; Olliaro, P